RELATED CONTENT
NEWS
- 'Microbiological finding' sees a halt to GSK/Anacor's antibiotic trials
- Avanir gains rights to Concert's 'heavy' Nuedexta dextromethorphan
- Rib-X inks potentially lucrative deal with Sanofi for new class of antibiotics
- MMV ups funding under deal with Anacor to allow Phase I trial of malaria candidate
ANALYSIS
Other Informa Analysis
FEATURES
- Piramal: regulatory overhaul would help India tackle disease challenges
- Merck BioVentures: where biosimilars make a difference
EVENTS
Today
Le Plaza Hotel, Brussels, Belgium
Today
Diplomat Hotel, Prague, Czech Republic
Today
Business Design Centre, London
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

